← Back to Search

Behavioural Intervention

Aromatherapy for Postoperative Care in Knee Replacement

N/A
Waitlist Available
Led By Uchenna Umeh, MD
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 18 and ≤ 80
Scheduled to undergo primary, unilateral knee replacement surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured pre-operatively, post-operative day (pod) 1, pod 2, pod 3, pod 7
Awards & highlights

Study Summary

This trial tests if aromatherapy may reduce post-op anxiety, pain, opioid use & nausea in total knee replacement patients.

Who is the study for?
This trial is for adults aged 18-80 scheduled for knee replacement surgery, who can consent and follow up, have a normal sense of smell, and experience anxiety. Excluded are those with severe allergies, liver or kidney issues, obesity (BMI ≥ 45), chronic pain or opioid use, certain heart conditions, nut allergies, or taking anxiety meds.Check my eligibility
What is being tested?
The study tests if Lavender-Peppermint Aromatherapy can reduce post-surgery anxiety, pain, opioid use and nausea/vomiting in knee replacement patients compared to an almond oil scent placebo. Participants will be randomly assigned to the aromatherapy or control group and complete questionnaires before and after surgery.See study design
What are the potential side effects?
Potential side effects may include allergic reactions due to sensitivity to the scents used in aromatherapy tabs. However, since this is not a drug intervention but rather an aromatic one using essential oils on tabs worn by patients; no significant systemic side effects are expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 19 and 80 years old.
Select...
I am scheduled for knee replacement surgery on one knee.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured pre-operatively, post-operative day (pod) 1, pod 2, pod 3, pod 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured pre-operatively, post-operative day (pod) 1, pod 2, pod 3, pod 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Anxiety level after surgery
The average pain score after surgery
Secondary outcome measures
Average post-operative opioid consumption
Average score on pain catastrophizing
Average score on pain interference
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Lavender-Peppermint Aromatherapy GroupExperimental Treatment1 Intervention
This is the interventional group. Participants in this group will receive aromatherapy tabs in the scent of lavender-peppermint. Tabs will be worn on a badge for a total of 72 hours, and participants will replace the aroma tabs every 12 hours.
Group II: Almond-oil Aromatherapy GroupPlacebo Group1 Intervention
This is the placebo group. Participants in this group will receive aromatherapy tabs in the scent of almond oil. Tabs will worn on a badge for a total of 72 hours, and participants will replace the aroma tabs every 12 hours.

Find a Location

Who is running the clinical trial?

Hospital for Special Surgery, New YorkLead Sponsor
244 Previous Clinical Trials
59,390 Total Patients Enrolled
2 Trials studying Depression
69 Patients Enrolled for Depression
Uchenna Umeh, MDPrincipal InvestigatorHospital for Special Surgery, New York
4 Previous Clinical Trials
324 Total Patients Enrolled
~19 spots leftby May 2025